PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hot topics in chemical biology and drug development at EB2011

4 sessions to unveil groundbreaking cellular analysis tools, drug-delivery methods

2011-04-08
(Press-News.org) WASHINGTON, April 7, 2011 – What do blinking fireflies, the cellular power plants that are human mitochondria, parasitic worms in sub-Saharan Africa and synthetic sugars have in common? At first glance, not a lot; but, after a good hard look, they represent bright threads in the tapestry of knowledge for those trying to patch the gaps between chemical biology, technology, therapies and cures.

In the coming days, as part of the Experimental Biology 2011 conference in Washington, D.C., two dozen researchers will go public about their ongoing work aimed at improving our understanding of biological systems and contributing to our cache of healing compounds.

Additionally, at the special four-day program sponsored by the American Society for Biochemistry and Molecular Biology, the work of 12 scientists who are making some of the hottest advances in technology and drug discovery will be showcased.

The dozen 25-minute talks and 12 other shorter presentations will be given in Room 207B of the Walter E. Washington Convention Center.

"We have a fantastic lineup of speakers who will address many different aspects of chemical biology and drug development," said organizer Shana O. Kelley. "We will hear from scientists developing powerful tools for cellular analysis, as well as those who study the molecules that cause disease and the development of new molecules that can treat disease."

The program will be divided into the following four themes:

The Chemical Biologist's Toolbox

The first session, to be held from 9:55 a.m. to 12:10 p.m. Sunday, will highlight new tools being used to reveal the chemical details of biological phenomena. These tools allow researchers to approach biological problems from new perspectives, often at a molecular level, and inside living organisms.

A team of collaborators from Lawrence Berkeley National Laboratory and the University of California, Berkeley, has developed a biological probe based on luciferase, the enzyme that lights fireflies. The probe monitors hydrogen peroxide in mice noninvasively, allowing researchers to track infectious disease and cancer without harming the study animals or even shaving their fur.

A Wayne State University team is working to determine the spatial distribution of disease-specific proteins in tissue. They have developed a new method for imaging and simultaneous identification of biological compounds. According to researcher Sarah Trimpin, the team can directly identify proteins in mouse brain sections that are unique to a given region within < 0.001 of an inch. "This new mass-spectrometric technology is fast and will help researchers better understand the boundaries of diseased tissue," she explained.

Trimpin said she hopes it will accelerate researchers' understanding of the molecular basis of diseases such as cancer metastasis.

Meanwhile, a group at Washington University is developing new technologies to further probe protein structure under biological conditions.

"The high-resolution protein structures that you see on Wikipedia have been obtained by X-ray crystallography and nuclear magnetic resonance -- and these are important reference points for understanding proteins in biology," explains Michael L. Gross. However, he said, proteins don't do their jobs in isolation. "Rather, they work in complex biological media of cells in the presence of many other proteins and substances."

Gross and his team are pursuing mass-spectrometry-based methods to better understand protein function, folding and unfolding, and interactions in such complex states.

Peptide-Based Drug Delivery, Drug Discovery and Biomaterials

The second session, which will be held from 3:45 p.m. to 6 p.m. Monday, will highlight recent advances in the use of peptides as potential drugs and biological probes.

One research team, based at the University of Toronto and led by event organizer Kelley, has been working on delivering drugs to mitochondria, which provide cells with energy they need to move, divide, produce metabolites, contract and so forth.

"The mitochondria are the powerhouses of the cell and are often dysregulated in diseases like cancer," explains Kelley. "They have evolved to be difficult to penetrate, because energy production requires a tightly regulated barrier that allows only ion transport."

The challenge of mitochondrial targeting recently was overcome by Kelley's team's discovery of cell-permeable, engineered mitochondria-penetrating peptides. "Recently, we have harnessed these carriers for drug delivery and have discovered that their use presents unique advantages in circumventing drug resistance in cancer cells," Kelley said.

Because the team can hide drugs in the mitochondria of cells, the mechanisms that cells typically use to deactivate drugs don't work, Kelley explained, "and the fact that the mitochondria are difficult to penetrate prevents cells from devising a quick solutions to counteract the toxicity of chemotherapeutics."

Novel Approaches to High-Throughput Drug Discovery

The third session, which will be held from 9:55 a.m. to 12:10 p.m. Tuesday, will focus on high-throughput methods for drug discovery and understanding disease progression. High-throughput screening allows for the automation of millions of biochemical, genetic or pharmacological tests through the use of robotics, software, and sample handling and detection devices.

Among the speakers for this session is Michelle Arkin of the University of California, San Francisco, whose work focuses on often-neglected tropical diseases that primarily affect the very poor in developing countries.

Schistosomiasis, one of the diseases Arkin's team is studying, is caused by parasitic worms and is acquired through contact with contaminated water. "It infects at least 200 million people, particularly children, in sub-Saharan Africa and parts of Asia and South America," Arkin said, but using high-throughput robotics and imaging technologies allows for the characterization of how drugs work and testing many more compounds than was previously possible.

"Applying high-throughput technology to this and other parasitic diseases will eventually improve drug options for patients, Arkin said. "Furthermore, applying the team's tools to new diseases pushes the technology in new directions."

The Chemical Biology of Human Disease

The fourth and final session, to be held from 1:45 p.m. to 4 p.m. Wednesday, will look at the merging of chemistry and biology to better understand disease states at a molecular level and to advance the development of novel therapeutics.

Among the presenters will be Peter H. Seeberger, a researcher at the Max Planck Institute in Germany, whose team is creating synthetic sugars as a means to fight disease in the developing world.

"I will speak about the use of synthetic sugars made using an automated synthesizer to find the malaria toxin that kills about 2 million children per year," Seeberger said. "This synthetic sugar is the basis for an anti-toxin malaria vaccine candidate we are currently developing."

A research team at Wayne State University led by event organizer Hendrickson is looking at a common lipid modification of proteins called GPI membrane anchoring, a process that is upregulated in many types of cancer.

"The enzyme that attaches these glycolipids to proteins is perhaps the last major protein modification enzyme that remains poorly understood," Hendrickson noted. "This dearth in knowledge is because it is membrane-associated, and there is not a robust high-throughput (test) to facilitate its characterization."

Hendrickson's research group is developing a test for this enzyme and also is evaluating how it assembles. She said she hopes that her work will eventually lead to a detailed understanding of the role of the enzyme, called GPI transamidase, in cancer.

### About Experimental Biology 2011 Experimental Biology is an annual gathering of six scientific societies that this year is expected to draw 13,000-plus independent scientists and exhibitors. The American Society for Biochemistry and Molecular Biology (ASBMB) is a co-sponsor of the meeting, along with the American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).

More information about EB2011 for the media can be found on the press page: http://experimentalbiology.org/content/PressInformation.aspx.

About the American Society for Biochemistry and Molecular Biology The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, at nonprofit research institutions and in industry. The Society's student members attend undergraduate or graduate institutions. For more information about ASBMB, visit www.asbmb.org.


ELSE PRESS RELEASES FROM THIS DATE:

Findings may help keep pancreatic disease off the menu

2011-04-08
WASHINGTON, April 7, 2011 – Timing is everything. That's especially true when it comes to the activation of enzymes created by the pancreas to break down food. When the timing is right, those enzymes are activated only when they reach the gut, where they get to work releasing and distributing nutrients that we need to survive. If the timing is wrong and the enzymes are activated too soon, they break down the pancreas itself, which is painful and sometimes fatal. Fortunately, most of the time the body is a master timekeeper and has a game plan for what to do if a signaling ...

What's coming next in the biochemical battle of the bulge?

2011-04-08
WASHINGTON, April 7, 2011 -- Dozens of researchers in the coming days will lay out what's around the corner in the biochemical battle of the bulge as part of the Experimental Biology 2011 conference in Washington, D.C. The three-day program on obesity, sponsored by the American Society for Biochemistry and Molecular Biology's minority affairs committee, will showcase the work of scientists from all over the world who have their sights set on reversing the epidemic by laying bare and manipulating, to mankind's advantage, its molecular underpinnings. Nine 25-minute ...

Paycheck Software from Halfpricesoft Takes Sting out of Payroll Problems for Small Businesses in California

Paycheck Software from Halfpricesoft Takes Sting out of Payroll Problems for Small Businesses in California
2011-04-08
Many people who start their own successful companies are intelligent, have field experience and an entrepreneur spirit to get things done. However, when it comes to accounting, and in particular payroll software, they often stumble. That's why Halfpricesoft co-founder Dr Ge went to work creating ezPaycheck, and its latest version, ezPaycheck 2011 payroll software for California users. "For more than ten years I was a programmer and consultant," says Dr Ge. "During that time I discovered many small business owners often had one thing in common, regardless of their industry: ...

At EB2011: The role of metabolism in disease

2011-04-08
WASHINGTON, April 7, 2011 – Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive. Considering the fundamental importance of this chemical give-and-take, it's not surprising that metabolic dysfunctions can lead to serious diseases. Next week, experts on metabolism will convene for a thematic program, at the American Society for Biochemistry and Molecular Biology's ...

'Paperless' research to be highlighted at international conference

Paperless research to be highlighted at international conference
2011-04-08
New technology is revolutionizing the precise recording of history at an ancient, lost city, bucking a tradition that has been in place for centuries. University of Cincinnati researchers will present "The Paperless Project: The Use of iPads in the Excavations at Pompeii" at the 39th annual international conference of Computer Applications and Quantitative Methods in Archaeology (CAA). The conference takes place April 12-16 in Beijing, China. The iPad research experiment, led by Steven Ellis, UC assistant professor of classics, and John Wallrodt, a senior research associate ...

Unreliable 'outcomes' measures hamper efforts to assure better, safer care

2011-04-08
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert. Writing in the April issue of the journal Health Affairs, Peter J. Pronovost, M.D., Ph.D., a professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine, argues that as the desire to evaluate and improve health care intensifies, there remains little consensus as to which measures are scientifically ...

Evolution of the animal temperature sensor: The functional adaptation to environmental change

2011-04-08
The animals on the earth have adapted themselves to the environmental temperature changes such as hot in deserts, or cold in the glacial epochs. However, the molecular mechanism for adaptation to thermal environments in the evolutionary process involving temperature sensors was not well understood. Professor Makoto Tominaga and Assistant Professor Shigeru Saito at The National Institute for Physiological Sciences (Okazaki Institute for Integrative Bioscience) demonstrate that the molecule called TRP channels, serve as temperature sensors in animals, sense different temperature ...

Fukushima-related measurements by the CTBTO

2011-04-08
Since the double disaster of the 9.0 magnitude earthquake and tsunami that affected hundreds of thousands of people and seriously damaged the Fukushima Daichi power plant in Japan on 11 March 2011, minute traces of radioactive emissions from Fukushima have spread across the entire northern hemisphere. A monitoring network designed to detect signs of nuclear explosions picked up these traces from the stricken power plant. To date, more than 30 radionuclide stations that are part of the International Monitoring System (IMS) have provided information on the spread of radioactive ...

NASA telescopes join forces to observe unprecedented explosion

NASA telescopes join forces to observe unprecedented explosion
2011-04-08
WASHINGTON -- NASA's Swift, Hubble Space Telescope and Chandra X-ray Observatory have teamed up to study one of the most puzzling cosmic blasts yet observed. More than a week later, high-energy radiation continues to brighten and fade from its location. Astronomers say they have never seen anything this bright, long-lasting and variable before. Usually, gamma-ray bursts mark the destruction of a massive star, but flaring emission from these events never lasts more than a few hours. Although research is ongoing, astronomers say that the unusual blast likely arose when ...

Lifesaving antibiotics face doubtful future

2011-04-08
[April 7, 2011, WASHINGTON] – To head off a health care disaster, the Infectious Diseases Society of America (IDSA) has developed a plan to combat deadly antibiotic-resistant "super bugs" and is rolling out the multi-pronged plan today, on World Health Day 2011. Infections are becoming increasingly resistant to existing antibiotics, while the number of new antibiotics being developed has plummeted. IDSA warns that unless sweeping actions are taken now, the future could resemble the days before these miracle drugs were developed. People will die of common infections and ...

LAST 30 PRESS RELEASES:

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting

Early detection model for pancreatic necrosis improves patient outcomes

Poor vascular health accelerates brain ageing

[Press-News.org] Hot topics in chemical biology and drug development at EB2011
4 sessions to unveil groundbreaking cellular analysis tools, drug-delivery methods